Merck Divests Allergopharma to Dermapharm

20-Feb-2020 - Merck signed an agreement to sell its allergy business Allergopharma to Dermapharm Holding SE. The transaction, which is expected to close by the end of the second quarter 2020, is subject to regulatory approval and satisfaction of other customary closing conditions. Since 2007, Merck has made ...

Allergopharma Opens new Biopharmaceutical Production in Reinbek

06-Mar-2017 - Merck announced, that its allergy business Allergopharma opened its new biopharmaceutical production in Reinbek, near Hamburg. Torsten Albig, Minister President of the Schleswig-Holstein region, recognized the €42 million investment as a local milestone for the pharmaceutical industry as a key ...

Allergopharma and S-TARget therapeutics conclude licensing agreement

Objective is new generation of therapeutics for allergy treatment

04-Sep-2014 - Allergopharma, the Merck Business Unit Allergy, and S-TARget therapeutics (S-TARget), an Austrian biotechnology company which develops therapeutic preparations for all forms of allergies, have signed an exclusive licensing agreement. The main focus of this cooperation is the use of S-TARget ...

Allergopharma plans to invest € 40 million in production facility

16-Dec-2013 - Merck broke ground on a new production facility for its Allergopharma unit in Reinbek near Hamburg. The new facility, which is estimated to cost nearly € 40 million, will be used, among other things, to expand production to serve new markets such as China. In the two-story building, which will be ...